Top Story

Gram-negative infections exhibited higher multidrug resistance among pediatric cancer patients

February 26, 2015

MEMPHIS, Tenn. — Gram-negative bacteremia had a higher proportion and prevalence of multidrug-resistance compared with gram-positive bacteremia among pediatric cancer patients, according to data presented at the St. Jude/PIDS Pediatric Infectious Diseases Research Conference.

While MDR bacteremia represents a possible emerging threat to pediatric cancer patients, there is little evidence available depicting the burden of this disease, particularly in low- and middle-income countries.

Hazel B. Nichols, PhD In the Journals

Benefits of tamoxifen for breast cancer prevention vary among at-risk women

February 26, 2015
Although most women who use tamoxifen for breast cancer prevention will derive benefit, more attention must be paid to the risk–benefit profiles of certain…
Marily Tavenner

CMS completes first week of ICD-10 end-to-end testing

February 26, 2015
The CMS concluded its first successful end-to-end testing week of the new ICD-10 coding, the agency announced in a blog post. “Testing allows us to identify areas…
FDA News

FDA issues update on Sunscreen Innovation Act

February 26, 2015
The FDA has issued additional information on the agency’s review of sunscreen ingredients and the Sunscreen Innovation Act.Congress enacted the Sunscreen…
FDA NewsDrug Pipeline

FDA grants orphan drug status to Factor Xa inhibitor antidote

February 26, 2015
The FDA has granted orphan drug designation to andexanet alfa for the treatment of patients with serious, uncontrolled bleeding events or who require emergency surgery…
More News Headlines »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
thumbnail for video 4040822599001

Routine PSA screening for most men not ready for ‘prime time’

February 10, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »